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Introduction
Nanotechnology yields numerous nanomaterials with interesting properties, which can be exploited in a plethora of possible applications. The biomedical field, for instance, aims to apply these materials to develop novel or improve existing diagnostic and/or therapeutic strategies. [1] [2] [3] [4] A category of inorganic nanoparticles (NPs) for biomedical use that has received much attention over the last two decades, are iron oxide (IO)NPs. [5] By creating nanosized iron oxide particles, the material acquires superparamagnetic properties, which allows its implementation in biomarker and pathogen detection assays [6] [7] [8] , protein sequestration [8] , cell sorting [9] , drug delivery [10] and cancer treatment through hyperthermia. [5, 11] Importantly, IONPs can also be applied as contrast agents for magnetic resonance imaging (MRI). [12, 13] In this regard, FDA-approved dextran-coated IONPs (USA: Feridex®, EU: Endorem®) have been clinically applied for the MRI-guided detection of liver lesions and tumors, before the production was discontinued in 2009. [14, 15] This MRI susceptibility can furthermore be exploited for regenerative cell therapy, where stem cells are transplanted into damaged tissues to replace the latter or promote cell survival and tissue repair via the secretion of specific factors. [16, 17] To monitor the cell distribution and engraftment, such therapies require a non-invasive method to track the transplanted cells in vivo, which can be accomplished by ex vivo cell labeling prior to the transplantation. [16, 18] In the context of regenerative medicine, there is a large interest in IONP labeling of neural stem cells before transplantation into the neural trauma site. [17, 19, 20] Since IONP with a diameter below 10 nm are typically applied for this purpose, we synthesized IONPs with a core diameter of ˜4 nm. [21] Overall, cell survival is an inherent drawback to this therapeutic modality and IONPs should persist inside the cells to allow long-term cell tracking, they may not negatively affect cellular homeostasis. [18] Hence, IONP optimization in terms of nanosafety is of key importance. Previous work from our group on IONPs coated with poly(isobutylene-alt-maleic anhydride) grafted with dodecylamine (PMA) showed a disturbed cellular homeostasis at sublethal doses, making this construct less ideal for the labeling of neural cells. [22] Coating with the ligand 2,3-meso-dimercaptosuccinic acid (DMSA) could be a valuable alternative to improve the nanosafety profile. Indeed, DMSA is an FDA-approved chelator applied in case of lead intoxication and DMSA-IONPs show good biocompatibility both to neural cells in vitro and neural tissue in vivo. [23] [24] [25] In general, many hazard identification studies are initially performed in vitro applying cell lines given their easy accessibility and applicability. [26] [27] [28] [29] However, we and other groups have demonstrated that primary cells or stem cells often respond differently to NP exposure as compared to the cell line counterpart. [22, [30] [31] [32] In addition, murine cell types are regularly applied despite reported species-related variations in NP-induced effects, which impede the extrapolation of results towards possible human scenarios. [33] [34] [35] Although several groups investigated either the species or cell type associated diversity in NP-evoked responses, [36] [37] [38] such studies remain rare for neural cell types. Previous work from our group revealed cell type specific neurotoxicity profiles in response to PMA-IONPs. [22] Given the clear perturbation of cell homeostasis, the PMA-IONPs were considered less fit for neural stem cell labeling in the context of regenerative medicine. Hence, we set out to optimize the IONPs by applying a different coating. To investigate whether the cell type equally impacts nanosafety optimization studies we compared the nanosafety profile of DMSA-coated IONPs to the previously applied PMA-IONPs. Please note that the same PMA-IONP sample was applied as described in our previous work. [22] In short, we evaluated the cellular responses in neural cell types that could possibly be selected as an in vitro model for neural stem cell labeling prior to transplantation in regenerative medicine, namely neural stem cells (NSCs), a neural immortalized (progenitor) cell line and neuroblastoma (cancerous) cell line from both humans and mice. [26] [27] [28] This setup will allow us to rationally guide the cell type selection for future nanosafety studies in the context of biomedical applications.
Materials & methods

IONP synthesis and characterization
IONPs were synthesized and coated with either the meso-2,3-dimercaptosuccinic acid (DMSA) ligand or the polymer poly(isobutylene-alt-maleic anhydride) grafted with dodecylamine (PMA) according to established protocols previously applied by our group. [22, 25, [39] [40] [41] Following synthesis, the core diameter was measured using transmission electron microscopy (TEM, Jeol JEM3010). UV/VIS absorption spectroscopy (Agilent 8453 UV-visible Spectroscopy System) was applied to evaluate the spectral characteristics, and the concentrations of the dispersions were determined via UV/VIS absorption spectroscopy and inductively coupled plasma mass spectrometry (ICP-MS, 7700 Series ICP-MS from Agilent Technologies). Finally, the hydrodynamic diameter and zeta-potential were measured using a Zetasizer Nano ZS (Malvern Instruments). Detailed information on the synthesis and characterization procedures is provided in the Supplementary Information.
Cell culture
The human NSCs (hNSCs [42] ) were purchased from Invitrogen (Belgium). Both the murine NSCs (mNSCs [42] ) and human progenitor cell line (ReNcell VM [43] ) were obtained from Millipore (Belgium). Sigma (Belgium) provided the murine progenitor (C17.2 [44] ) and neuroblastoma (Neuro-2a [45] ) cell line. Finally, the human neuroblastoma cell line (LA-N-2 [46] ) was retrieved through the European Collection of Cell Cultures.
All cell types were cultured according to the manufacturers guidelines and kept at 37 °C in a humidified atmosphere completed with 5% CO 2 . Every other day, cells received fresh cell medium until 80% confluence was reached and the cells were passaged. Hereto, the cells were detached using 0.05% trypsin-EDTA (Invitrogen, Belgium), centrifuged 4 minutes at 300 g and seeded at appropriate densities. Experiments were performed on cells with a passage number below 20. Detailed cell culture protocols are provided in the Supplementary Information.
Cytotoxicity
Cells were seeded in opaque 96-well plates at a density of 25000 cells/well and were allowed to settle overnight. The subsequent 24 hours, cells were exposed to 3.5, 7, 14, 35, 70 and 140 nM IONP dispersions. Subsequently, the CellTiter-GLO ® assay (Promega, Belgium) was performed according to the manufacturer's instructions. Hereto, 100 µL of the assay buffer was added to each sample, plates were shaken during 2 minutes and following a 10-minute incubation, the signal was measured using a GloMax® 96 Luminometer (Promega, Belgium).
ROS and intracellular free calcium
Cells were seeded in 24-well plates at appropriate densities (Supplementary Information).
The cells were allowed to settle overnight before being exposed to 7, 14, 35, 70 or 140 nM IONP dispersions for 24 hours. Notably, since the applied NP dispersion volume was adjusted according to the cell density, the NP number/volume cell medium/cell number remained equal in all experiments (Table S1 ).
After discarding the IONP containing medium, the cells were labelled with CellROX ® green and Rhodamine-2 AM (Molecular Probes, Belgium) to allow visualization of reactive oxygen species (ROS) and free calcium present in the cytosol, respectively. Both were detected using the IN Cell analyser 2000 (GE Healthcare Life Sciences, Belgium) and the acquired data were analysed using in house developed protocols with the IN Cell Developer Toolbox software (GE Healthcare Life Sciences, Belgium). Detailed staining and analysis protocols are provided in the Supplementary Information.
Mitochondria and cell morphology
Cells were seeded at appropriate densities as described in the previous paragraph. The cells were allowed to settle overnight and were subsequently exposed to 3. 
Statistics
Cytotoxicity data are expressed as the mean ± standard error of the mean (SEM, n=3). IN Cell data are presented as the mean normalized against the untreated control ± SEM for two independent replicates, with a minimum of 10000 cells being analysed per replicate.
Statistical analysis was performed using the 6 th version of the GraphPad Prism software.
Treated samples were compared with the untreated control by means of one-way ANOVA combined with the post-hoc Dunnett test. Additionally, responses induced by the differently coated IONPs were compared with two-way ANOVA followed by the Bonferroni post-hoc test.
Results
IONP characterization
The core diameter (d c ) of the synthesized IONPs was quantified with transmission electron microscopy (TEM), which showed a mean value of 3.8 nm ( In addition, both IONPs showed a strong, negative charge of -55.5 ± 0.9 mV for the IONP-DMSA and -54 ± 2.2 mV for the IONP-PMA. [22] Further characterization in terms of the absorption spectra, molecular extinction coefficient, initial NP dispersion concentration and electrophoretic mobility is provided in the Supplementary Information (Tables S2 and S3, Figures S4 and S5).
Cytotoxicity
In a first set of cell-based experiments we evaluated the IONP-induced cell injury. Upon exposure to higher doses, several cell types experienced cell damage, which was most pronounced in the hNSCs ( Figure 2 ). In contrast, the murine Neuro-2a neuroblastoma cell line was most resilient to IONP exposure, as only the highest dose of PMA-IONPs evoked a minor, though significant, effect. In the majority of the cell types (the hNSCs, mNSCs and the murine C17.2 and Neuro-2a cell lines), the PMA-IONPs induced more severe effects than the DMSA-IONPs. However, in the ReNcell and LA-N-2 cell line, the opposite was true. Finally, when comparing the human cell types to their murine counterpart, the former appeared to be more sensitive, irrespective of the coating.
ROS production
To assess whether IONP exposure could affect the cell homeostasis at sublethal doses, we first looked into the effect of ROS production via staining with the CellROX ® green probe. [47] This is especially important in neural cells since (i) ROS is a key player in the initiation and progression of several neurodegenerative disorders and (ii) neural cells are especially sensitive to oxidative stress given their high metabolic rate and low anti-oxidative capacity. [48] Three responses could be distinguished; an increase, a decline or a steady state ( Figure 3 ). In case of the first two responses, the induced effects were IONP-concentration dependent. Similar to the cell damage, the observed changes in ROS levels were most pronounced in the NSCs. For instance, in the hNSCs the DMSA-coated IONPs evoked a threefold ROS induction at the highest concentration tested, whereas a decline was induced by the IONP-PMA. Notably, exact opposite trends were obtained in the mNSCs, indicating species-specific effects. Likewise, in the human progenitor cell line (ReNcell), both IONPs caused ROS induction whereas a decline was seen in the murine counterpart (C17.2). In contrast, in both neuroblastoma cell lines only the PMA-coated IONPs significantly reduced ROS. Overall, the PMA-IONPs evoked more severe effects in the included cell lines but no general statements can be made on the interspecies variations. 
Mitochondrial homeostasis
In turn, the mitochondria provide the bulk of the cellular energy, require Ca 2+ signaling for their function, produce significant amounts of ROS and are associated with programmed cell death. [53, 54] In addition, the Δ Ψm is a known effector in neurodegenerative disorders. [55] When the Δ Ψm is compromised, the mitochondria fail to produce ATP and cytochrome C can be released, followed by the initiation of apoptosis. [53, 56] These organelles were labeled with Mitotracker® CMX-ROS Red, which accumulates in the organelle based on the mitochondrial membrane potential (Δ Ψm ). When the Δ Ψm is compromised due to NPs directly interacting with the mitochondrial membrane or ROS-induced membrane damage, the dye can no longer accumulate and the mitochondrial signal area relative to the total cell area decreases.
[57] Figure 5 shows the relative signal area to be reduced or unaffected by IONP exposure. The latter was true for both IONPs in the Neuro-2a cell line and the C17.2 cells exposed to DMSA-IONPs. In all other cases the IONPs significantly reduced the Δ Ψm . Notably, the ReNcells were most severely affected by both IONPs, followed by the hNSCs. Similar to the cytotoxicity observations, the human cell types were more sensitive to IONP exposure than the murine counterparts. On the whole, the onset of the effect occurred at lower doses for the IONP-PMA and effects were significantly more severe as compared to the DMSAIONPs, except in the LA-N-2 neuroblastoma cells where no significant differences were detected between both IONPs.
Cell morphology
Following cell labeling with HCS CellMask ™ Blue, cell morphology was evaluated in terms of cell area and cell circularity. [22] The latter is defined as a value between zero and one, with one representing a perfect sphere. Thus, a lower value corresponds to a more complex cell morphology whereas an increase due to IONP exposure points to cell rounding and loss of specific morphological features, such as neurite outgrowths. [22] Cell morphology is a convenient parameter to include in a multiparametric analysis, as cell death has specific morphological features whereas minor alterations to cytoskeleton building blocks can impair cell functions that require signaling via these components. [48, 50, 58, 59] Figure 6 reveals that the effect of the PMA-IONPs on cell morphology was overall more severe, with the exception of the mNSCs. In the latter, both cell area and circularity were significantly affected by the lowest and highest dose of DMSA-IONPs and PMA-IONPs, respectively. 
Discussion
In this study, we evaluated the extent at which DMSA-and PMA-coated IONPs induced adverse effects in six neural cell types, namely NSCs, a progenitor cell line and a cancer cell line from murine and human origin. Please note that the same PMA-IONP sample was applied as in previous work, where we observed clear dose-and cell type-dependent neurotoxicity. [22] The specific aim of this work was to evaluate if such adverse effects could be similarly alleviated in the distinct cell types by applying a different coating strategy. The cell types were selected based on an important future application of the IONPs, i.e. neural cell labeling to allow MRI-guided in vivo cell tracking following transplantation in the context of regenerative cell therapy for neural lesions. Multiple studies regarding this topic apply various cell models without clearly specifying the species and or cell type (immortalized or cancer cell line, primary cells, stem cells). [26] [27] [28] Since NP-evoked effects can differ widely amongst various cell models, [33, 35] we evaluated the impact of the cell model on nanosafety optimization studies. Hereto, we looked into the impact of both the cell type and species in one single study in contrast to previous reports focusing on a single variable. [34, 37, 38] IONP characterization showed that DMSA-and PMA-IONPs had similar basic physicochemical properties, in line with previous reports. [22, 25, 39, 60] This was desirable as potentially distinct cell responses could be explained in terms of how the cell models interact with the NPs, rather than by the intrinsic physicochemical properties of the IONPs.
Overall, we found the DMSA-IONPs to evoke less extensive responses than the PMA-IONPs.
In four out of six cell types DMSA-IONPs induced less cytotoxicity than the PMA-IONPs, as expected based on recent literature. [23] [24] [25] However, the observed toxicity for DMSA-IONPs was slightly more severe than anticipated, possibly due to the greater sensitivity of neural cells towards NP exposure in general. [16] Cell homeostasis was furthermore perturbed at sublethal IONP doses in nearly all combinations tested. In correspondence with previous reports, we witnessed unaffected, decreased or induced ROS levels, [55, 61, 62] which was more outspoken for the PMA-IONPs. The decreased ROS levels can be explained in terms of the intrinsic scavenging potential of intact IONPs or the cellular adaptation to the response of foreign materials. [63, 64] The steady state observed for DMSA-IONPs in the cancer cell lines can be attributed to the chelating capacity of DMSA, preventing leached iron ions from inducing ROS. [14, 23, 25] Still, the DMSA-IONPs were found to significantly induce ROS in the hNSCs and ReNcells, possibly indicating that the extent of ion leaching outweighed the DMSA chelating capacity or that ROS induction in part occurred through alternate mechanisms. Moreover, ROS induction is an acute event depending on the kinetics of NP uptake, intracellular trafficking, the stability of the applied coating and ion leaching. [14, 65] Hence, variations in any of these processes could in part explain the distinct responses.
Finally, variations between human and murine cell types may stem from differences in the anti-oxidative capacity, which was reported to be elevated in mice. [66] In addition, the DMSA-IONPs most often showed less pronounced responses on the level of the calcium and mitochondrial homeostasis and cell morphology. Since all responses can to a certain extent be correlated to ROS production, [65, 67] the chelating capacity of DMSA may in part be accountable for the improved nanosafety profile. However, additional elements may impact the safety profiles. For one, different coating materials will acquire different proteins at their surface. This differential protein corona can in turn influence the extent of NP uptake, the exploited uptake pathway(s) and subsequent cellular processing. [68] In addition, not all coating materials equally protect the IONP surface against the acidic pH and hydrolases in the lysosomes. [69] Of note, the coating itself may in turn be sensitive to lysosomal degradation and released degradation products can also affect the cell homeostasis. [70] Hence, further research will be required to unveil the exact mechanism behind the improved biocompatibility of DMSA-IONPs.
From the multiparametric data set in each cell type alone it would be concluded that the DMSA-IONPs are the preferred candidate for further optimization since they generally evoked less severe effects, regardless of the distinct culture medium composition for the different cell types. The cell media could potentially influence IONP uptake through an impact on the colloidal stability and the formation of a protein corona. [71, 72] Such variations in IONP uptake could certainly impact the evoked effects, although a linear relationship between the intracellular NP dose and the cytotoxicity is not always evident. [35] Hence, these parameters were not investigated in detail since we preferentially focused on investigating how various cell models (i.e. the cell type and its optimal medium) respond to IONP exposure. Furthermore, adequate IONP uptake and colloidal stability were previously documented for the applied coating materials. [24, 47, 73] Nevertheless, further characterization of the protein corona and IONP uptake in the applied cell models would improve our understanding of the observed adverse events. [74] Most importantly, a correct conclusion on the preferable IONP coating for the envisioned application could only be reached when a multiparametric approach was applied, as in rare cases the DMSA-IONPs more severely perturbed cell homeostasis. Overall, a distinct nanotoxicity profile was obtained in each applied cell model. The sensitivity of the cell model was furthermore clearly species-related, as human cell types were more sensitive towards DMSA-IONP-induced effects. Likewise, Zhang et al. found human macrophages to be more sensitive towards DMSA-IONPs than the murine alternative. [75] Secondly, the cell type was a major factor since for both the human and murine cell types the NSCs were found to be most sensitive towards both IONPs, whereas the cancer cell lines were most resilient. This is in agreement with the observation that tumor cells have several characteristics making them less prone to NP-induced effects, as cell transformation or immortalization is accompanied by phenotypical changes on the level of cell morphology, metabolic rate, proliferation rate, etc. [33, 76] Hence, intrinsic variations between cell types can at least in part be held accountable for the observed variations, as more elaborately described previously. [77] Finally, not all cell models showed a similar sensitivity on all evaluated end points. For instance, no significant differences could be detected in IONP-induced mitochondrial damage in the cancer cell lines, while this was true for all other cell types. Hence, nanosafety screenings to define suitable NPs for a certain application should be performed in a multiparametric fashion evaluating sensitive and informative end points in sufficiently sensitive cell types.
To progress towards a clinical application, we should further investigate whether our cell labeling protocol allows sufficient IONP internalization to allow cell detection through MRI, as labeling parameters are reported to influence the MRI visibility. 
Conclusion
IONPs are of interest as MRI contrast agents for the labeling of transplanted neural stem cells (NSCs), albeit that nanotoxicity remains a concern. Cell-nanoparticle interactions of DMSA-and PMA-coated IONPs were investigated in human and murine NSC, neural progenitor and neuroblastoma cells. The overall nanosafety profile of the DMSA-IONPs was superior compared to the PMA-IONPs. Importantly, a multiparametric approach was required to reach this conclusion. In the cell lines we predominantly found both IONPs to evoke similar responses. In contrast, clear interspecies variations were detected on ROS production and Ca 2+ homeostasis in the NSCs, where both IONPs were found to evoke opposite effects. This is an important observation, as the hNSCs are considered to be the most representative model for the envisioned application. Thus, the DMSA-coating could not in all cell types equally alleviate the induced nanotoxicity compared to the PMA-IONPs.
Overall, sufficiently sensitive cell lines can be applied when performing a multiparametric screening to define suitable candidates for a certain biomedical application. However, further thorough safety evaluations should be performed on a non-cancerous human cell model most closely resembling the target cell or tissue whenever possible. The effect on cell morphology of 24 hours exposure to DMSA-IONPs (top row) and PMAIONPs (lower row) represented as changes in relative cell area (black bars) and cell circularity (blue lines). In general cell circularity is a more sensitive parameter and DMSA-IONPs induce least severe effects. Statistical significance with regard to the untreated control is indicated when appropriate in the corresponding color, black for cell area and blue for circularity (* p < 0.05). (NTC = not treated control) 
